M&A
-
Representations and the limits of deceit in M&A transactions
The judgment sends a powerful message about the limits of deceit in heavily negotiated M&A transactions and the high threshold for these types of claims.
-
Navigating CRD VI – the impact on M&A transactions
In the first of three articles we focus on new harmonized regulatory requirements that apply to certain types of M&A transactions in the EU banking sector.
-
Podcast: Jeffrey Oliver tells us about the state of antitrust policy and enforcement in 2026
Jeffrey Oliver talked to GRIP about the surging pace of antitrust activity in 2026 and what we can expect from regulators in this space.
-
Podcast: Barry Posner on healthcare M&A diligence and regulatory change
Against a backdrop of uncertain times for healthcare M&A, we spoke to Barry Posner, partner at Kudman Trachten Aloe Posner LLP.
-
Canada’s SAR pilot program and a possible rule change from the SEC
Voluntarily adoption of semi-annual financial reporting (SAR) as part of a multi-year pilot is inline with SEC Chair Atkins supporting a shift from quarterly reporting.
-
FINRA to revise day trading to attract more retail investors
Going to the SEC for approval are also proposals for revised corporate financing rules, outside activities requirements, and an increase to the gift limit.
-
GRIP Extra: WhatsApp ads and India regulatory reforms
Our in-brief summation of notable stories from last week.
-
Regulatory due diligence: What’s next for consolidators?
M&A activity could see an amalgamation of the consolidators as private equity seeks to exit its investments, realising its gains.